在青少年暴露于酒精时调节p75NTR可以防止胆固醇神经缩和相关的乙胆活性和行为功能障碍
1Department of Psychology, Binghamton University-State University of New York, Binghamton, NY 13902, USA.
International journal of molecular sciences
|June 19, 2024
概括
青少年过度饮酒会通过影响大脑路径,损害学习和注意力. 一种向p75神经质受体 (p75NTR) 的药物,在动物模型中被保护免受这些有害影响.
科学领域:
- 神经科学是一个神经科学.
- 神经生物学 神经生物学 神经生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 青少年过度饮酒会导致持久的认知缺陷,增加成风险.
- 基底细胞核巨细胞核 (NbM) 参与这些缺陷,调节前额叶皮层 (PFC) 胆功能和注意力.
- 胆固醇表型是通过亲/成熟的神经类受体 (p75NTR) 信号调节的.
研究的目的:
- 调查p75NTR活性在青少年间歇性乙醇 (AIE) 诱导的胆性退行症中的作用.
- 为了确定是否抑制p75NTR与LM11A-31的信号传递可以预防AIE相关的认知和神经生物学缺陷.
主要方法:
- 鼠被暴露在青少年间歇性乙醇 (AIE) 或对照条件下,其中一些接受了LM11A-31.
- 行为测试包括持续关注任务 (SAT).
- 测量了前额叶皮层 (PFC) 乙胆 (ACh) 活性和NbM神经元表达 (ChAT+,TrkA+).
主要成果:
- AIE暴露导致SAT的学习缺陷,并削弱了PFC ACh活动.
- 治疗LM11A-31预防了SAT缺陷,并使PFC ACh活动正常化.
- AIE减少了NbM中的ChAT+TrkA+神经元,这种效应被LM11A-31逆转.
结论:
- p75NTR信号传递是青少年过度饮酒引起的胆固醇神经退行症的关键调解者.
- 用LM11A-31抑制p75NTR提供了一种潜在的治疗策略,以减轻青少年暴露于酒精的长期后果.
更多相关视频
09:50Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice
Published on: April 24, 2013
11.8K
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
887
相关概念视频
01:27CNS Depressants: Alcohol and Nicotine
202
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
202
01:22Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179